In the Netherlands, observed putative PGVs in dominant genes that do not match the tumor type (ATR, CHEK2 (3x), SDHA and MITF) are normally not reported back to the patient, except if there is a matching personal and/or familial history. Here, CHEK2 is linked to neoplasm.